In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...

Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the aggressive form of skin cancer, Merkel cell ...

Merkel cell carcinoma, or MCC, is so rare that newly diagnosed patients are often the first case their oncologist has ever treated. For many patients, understanding this aggressive skin cancer’s ...

Cancer is a famously complex disease. Despite sharing the ‘cancer’ label, different cancer types can be as structurally and functionally diverse as the tissues from which they arise—physicians and ...

BIRMINGHAM, Ala. – Transduction is the changing of one form of energy into another, such as a spoken voice changed into radio waves by a cellphone. Ten years ago, three research teams published a ...

ctDNA testing effectively stratifies Merkel cell carcinoma patients into high and low recurrence risk categories, influencing surveillance strategies. The study's cohorts revealed significant ...

Merkel cell carcinoma (MCC) is an aggressive skin cancer with a 40% recurrence rate, lacking effective prognostic biomarkers and surveillance methods. This prospective, multicenter, observational ...